Neonatal Presentation of Osteogenesis Imperfecta
DOI:
https://doi.org/10.51481/amc.v51i2.231Keywords:
osteogenesis imperfecta, neonates, type I protocollagenAbstract
We report the case of a male patient with one day of life, his mother is a 20-yr-old gravida 1 para 1 male, there is parental consanguinity (second cousin). This patient born alive by Caesarean section in breech presentation with meconiumstained amniotic fluid and birthweight 2275 g (small for gestational age term infant). Physical examination findings in this case are hypotonia, mild cyanosis, large anterior fontanelle, absence of occipital scale, blue sclera, retrognathia and shortening of the long bones whit crepitation. The radiografphic findings show numerous fractures, hyperplastic callus formation and dysplastic changes in metaphyses. He was diagnosed by the geneticists with OI and given genetic counseling to parents. The osteogenesis imperfecta has a genetic background that affects connective tissue integrity, associated with collagen synthesis mutations, being dominant or recessive autosomic inheritance. In the majority of cases, diagnosis of IO is easy on the basis of clinical and radiological findings; for this reason must be important to emphasize on bone structure studies, because patients may develop cystic, dense or fragile changes. This case presents a patient who has osteogenesis imperfecta type II; we pretend to discuss the differences between Ol's types.
Downloads
References
Hoffman, Jodi D, Estrella E.Newborn. Presentation of connective tissue disorders. NeoReviews. 2007; 8: 110-119.
Niyibizi C, Smith P, Zhibao M, Robbins P, Evans C. Potential of gene terapy for treating osteogenesis imperfecta. Clin Otrthop and Relat Reser, 2000; 379: 126-133.
Mihran O, Tachdjlan M. Pediatric Orthopedics. 1990; 2 ed Saunders Company; Vol II: 1-3366.
Paterson Colin R, McAllion Susan J. Classical Osteogenesis Imperfecta and Allegations of Nonaccidental Injury Clin Orthop and Relat Reser, 2006; 452: 260-264
Devogelaer J. New uses of biphosphonates: osteogenmesis imperfecta. Current Opinion in Pharmacol. 2002; 2:748-753.
Peter H. Byers. Osteogenesis imperfecta: perspectives and opportunities. Current Opinion in Pediatrics, 2000;12:603-609.
Astrom E, Soderhall S. Beneficial effect of biphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paedriatr 1998;87:64-68
Jones, K. Smit´s. Recognizable Patterns of Human Malformation. 1997; 5 ed. Saunders Company. Páginas 123-125.
Hanscom DA, Winter RB, Lutter L, Lonstein JE. Osteogenesis imperfecta: Radiographic classification, natural history, and treatment.
J Bone Joint Surg Am. 1992; 74:598-616.
Downloads
Published
Issue
Section
License
Copyright (c) 2009 Acta Médica Costarricense

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)



